Research Reports | Market Assessment
June 2023

Ulcerative Colitis – Access & Reimbursement – Detailed, Expanded Analysis: Ulcerative Colitis And Crohn’s Disease (US)

Table of contents

  • Ulcerative Colitis - Access & Reimbursement - Detailed, Expanded Analysis: Ulcerative Colitis And Crohn's Disease (US)
    • Access & Reimbursement UC & CD US July 2023
Ritesh Gupta, Ph.D.
Ritesh Gupta, Ph.D.

Ritesh Gupta, Ph.D., Senior Healthcare Research & Data Analyst, Immune and Inflammation. Dr. Gupta’s focus is inflammatory bowel disease market. He has years of experience in competitive intelligence, scientific analysis, and market opportunity assessment and has worked in various therapeutic areas to provide strategic recommendations to pharmaceutical companies. He holds a Ph.D. in cell biology from the Max Delbrück Center for Molecular Medicine in Berlin.

Chris Lewis
Chris Lewis

Chris Lewis, Lead Healthcare Research & Data Analyst, U.S. Access and Reimbursement.  Ms. Lewis oversees Clarivate’s U.S. Access & Reimbursement reports, including managing the primary research activities, reviewing content, and authoring select A&R reports on managed care trends. A Clarivate employee for 16 years, Ms. Lewis previously was a senior analyst who authored Health Plan Analysis reports and PBM profiles. She received her bachelor’s degree from California State University in Sacramento.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports